tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Bryan Brokmeier, 35 are a BUY (97.22%), 1 are a HOLD (2.78%).
Analyst Bryan Brokmeier, carries an average stock price target met ratio of 81.82% that have a potential upside of 58.4% achieved within 450 days. Previously, Bryan Brokmeier worked at CANTOR FITZGERALD.
Bryan Brokmeier’s has documented 66 price targets and ratings displayed on 13 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on TTOO, T2 Biosystms at 03-May-2017.
Analyst best performing recommendations are on NEON.
The best stock recommendation documented was for NEON at 4/26/2017. The price target of $11 was fulfilled within 16 days with a profit of $6.2 (36.05%) receiving and performance score of 22.53.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 04-Jan-2019
$1.35
$-1.19 (-46.85%)
28 days ago
(09-Sep-2026)
5/5 (100%)
$0.06 (4.65%)
81
Sell Since 14-Apr-2026
$1.5
$-0.15 (-9.09%)
$1
4 months 26 days ago
(11-May-2026)
5/8 (62.5%)
$0.14 (10.29%)
25
Hold Since 16-May-2022
$2
$0.35 (21.21%)
$1.5
10 months 26 days ago
(11-Nov-2025)
13/14 (92.86%)
$0.14 (7.53%)
98
Buy Since 18-Feb-2025
$2
$0.35 (21.21%)
$1.8
10 months 27 days ago
(10-Nov-2025)
3/3 (100%)
$0.24 (13.64%)
150
Buy Since 10-Jun-2020
$3
$1.35 (81.82%)
$3
11 months 22 days ago
(15-Oct-2025)
5/12 (41.67%)
$1.26 (72.41%)
160
